Evidence map›Paper›PMID 41958539›Full record

ArticleACS materials letters2026

A Structurally Dynamic Pathogen-Mimicking Biomaterial Is an Efficient Activator of Dendritic Cells.

Hèctor López-Laguna, Marianna T P Favaro, Sara Chellou-Bakkali, Eric Voltà-Durán, Eloi Parladé, Merce Márquez-Martínez, Manuela Costa, Nerea Roher, Antonio Villaverde, Esther Vázquez

Abstract read
In one paragraph

Article in ACS materials letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hèctor López-LagunaInstitut de Biotecnologia i de Biomedicina (IBB), Universitat Autònoma de Barcelona, Barcelona 08193, Spain.
Marianna T P FavaroInstitut de Biotecnologia i de Biomedicina (IBB), Universitat Autònoma de Barcelona, Barcelona 08193, Spain.ORCID https://orcid.org/0000-0003-2942-247X
Sara Chellou-BakkaliInstitut de Biotecnologia i de Biomedicina (IBB), Universitat Autònoma de Barcelona, Barcelona 08193, Spain.
Eric Voltà-DuránInstitut de Biotecnologia i de Biomedicina (IBB), Universitat Autònoma de Barcelona, Barcelona 08193, Spain.
Eloi ParladéCentro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, Madrid 28029, Spain.ORCID https://orcid.org/0000-0001-5750-550X
Merce Márquez-MartínezInstitut de Biotecnologia i de Biomedicina (IBB), Universitat Autònoma de Barcelona, Barcelona 08193, Spain.
Manuela CostaServei de Cultius Cel·lulars, Anticossos i Citometria (SCAC), Universitat Autònoma de Barcelona, Barcelona 08193, Spain.
Nerea RoherInstitut de Biotecnologia i de Biomedicina (IBB), Universitat Autònoma de Barcelona, Barcelona 08193, Spain.
Antonio VillaverdeInstitut de Biotecnologia i de Biomedicina (IBB), Universitat Autònoma de Barcelona, Barcelona 08193, Spain.ORCID https://orcid.org/0000-0002-2615-4521
Esther VázquezInstitut de Biotecnologia i de Biomedicina (IBB), Universitat Autònoma de Barcelona, Barcelona 08193, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Structural dynamism confers intriguing applications to biocompatible materials. Here, we present a protein-based, self-organizing microscale material designed to mimic pathogen-like features. In this formulation, the building block proteins shift their organization through monomeric, microscale, or oligomeric nanoscale states, which is expected to enhance antigen uptake and immune activation. To validate the system, several CT26-derived tumor neoantigens, namely, Ubqln1, AHSL and Phf3, have been assembled as mixed granules, leaking nanoscale protein oligomers. When challenging dendritic cells, this formulation enhanced the expression of the activation markers CD40 and MHC II compared with soluble antigens, underscoring the material's ability to potentiate antigen-presenting functions. While many antigens are attractive targets due to their unique expression in malignant cells, their poor immunogenicity in soluble versions may render them ineffective. The present approach represents a transversal and feasible tool to enhance the immunogenicity of protein antigens through a dynamic material platform that expands their translational potential.

Identifiers

PMID41958539
PMCPMC13058948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.